Display Settings:

Format

Send to:

Choose Destination
    Am J Hematol. 2011 Nov;86(11):958-61. doi: 10.1002/ajh.22146. Epub 2011 Sep 21.

    Feasibility and benefit of hydroxycarbamide as a long-term treatment for sickle cell disease patients: results from the North West London Sickle Cell Disease Registry.

    Source

    Department of Haematology, Central Middlesex Hospital, London, United Kingdom. annette.gilmore@nhs.net

    PMID:
    21948113
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for John Wiley & Sons, Inc.

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk